HEADER LIPID TRANSPORT 14-JUL-21 7P5J TITLE CRYO-EM STRUCTURE OF HUMAN TTYH1 IN GDN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN TWEETY HOMOLOG 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HTTY1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTYH1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS MEMBRANE PROTEIN, LIPID METABOLISM, LIPID TRANSPORT EXPDTA ELECTRON MICROSCOPY AUTHOR A.SUKALSKAIA,M.S.STRAUB,M.SAWICKA,D.DENEKA,R.DUTZLER REVDAT 3 08-SEP-21 7P5J 1 JRNL REVDAT 2 25-AUG-21 7P5J 1 AUTHOR JRNL REVDAT 1 11-AUG-21 7P5J 0 JRNL AUTH A.SUKALSKAIA,M.S.STRAUB,D.DENEKA,M.SAWICKA,R.DUTZLER JRNL TITL CRYO-EM STRUCTURES OF THE TTYH FAMILY REVEAL A NOVEL JRNL TITL 2 ARCHITECTURE FOR LIPID INTERACTIONS. JRNL REF NAT COMMUN V. 12 4893 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34385445 JRNL DOI 10.1038/S41467-021-25106-4 REMARK 2 REMARK 2 RESOLUTION. 4.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.000 REMARK 3 NUMBER OF PARTICLES : 94925 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7P5J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1292117043. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : TTYH1 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6100.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 ALA A 3 REMARK 465 PRO A 4 REMARK 465 CYS A 71 REMARK 465 CYS A 72 REMARK 465 ARG A 73 REMARK 465 PRO A 74 REMARK 465 PRO A 75 REMARK 465 GLU A 76 REMARK 465 PRO A 77 REMARK 465 PRO A 78 REMARK 465 GLY A 79 REMARK 465 SER A 80 REMARK 465 LYS A 81 REMARK 465 ILE A 82 REMARK 465 PRO A 83 REMARK 465 SER A 84 REMARK 465 PRO A 85 REMARK 465 GLY A 86 REMARK 465 GLY A 87 REMARK 465 GLY A 88 REMARK 465 CYS A 89 REMARK 465 SER A 423 REMARK 465 ASP A 424 REMARK 465 ASP A 425 REMARK 465 TYR A 426 REMARK 465 ASP A 427 REMARK 465 ASP A 428 REMARK 465 THR A 429 REMARK 465 ASP A 430 REMARK 465 ASP A 431 REMARK 465 ASP A 432 REMARK 465 ASP A 433 REMARK 465 PRO A 434 REMARK 465 PHE A 435 REMARK 465 ASN A 436 REMARK 465 PRO A 437 REMARK 465 GLN A 438 REMARK 465 GLU A 439 REMARK 465 SER A 440 REMARK 465 LYS A 441 REMARK 465 ARG A 442 REMARK 465 PHE A 443 REMARK 465 VAL A 444 REMARK 465 GLN A 445 REMARK 465 TRP A 446 REMARK 465 GLN A 447 REMARK 465 SER A 448 REMARK 465 SER A 449 REMARK 465 ILE A 450 REMARK 465 ALA A 451 REMARK 465 LEU A 452 REMARK 465 GLU A 453 REMARK 465 VAL A 454 REMARK 465 LEU A 455 REMARK 465 PHE A 456 REMARK 465 GLN A 457 REMARK 465 MET B 0 REMARK 465 SER B 1 REMARK 465 GLY B 2 REMARK 465 ALA B 3 REMARK 465 PRO B 4 REMARK 465 CYS B 71 REMARK 465 CYS B 72 REMARK 465 ARG B 73 REMARK 465 PRO B 74 REMARK 465 PRO B 75 REMARK 465 GLU B 76 REMARK 465 PRO B 77 REMARK 465 PRO B 78 REMARK 465 GLY B 79 REMARK 465 SER B 80 REMARK 465 LYS B 81 REMARK 465 ILE B 82 REMARK 465 PRO B 83 REMARK 465 SER B 84 REMARK 465 PRO B 85 REMARK 465 GLY B 86 REMARK 465 GLY B 87 REMARK 465 GLY B 88 REMARK 465 CYS B 89 REMARK 465 SER B 423 REMARK 465 ASP B 424 REMARK 465 ASP B 425 REMARK 465 TYR B 426 REMARK 465 ASP B 427 REMARK 465 ASP B 428 REMARK 465 THR B 429 REMARK 465 ASP B 430 REMARK 465 ASP B 431 REMARK 465 ASP B 432 REMARK 465 ASP B 433 REMARK 465 PRO B 434 REMARK 465 PHE B 435 REMARK 465 ASN B 436 REMARK 465 PRO B 437 REMARK 465 GLN B 438 REMARK 465 GLU B 439 REMARK 465 SER B 440 REMARK 465 LYS B 441 REMARK 465 ARG B 442 REMARK 465 PHE B 443 REMARK 465 VAL B 444 REMARK 465 GLN B 445 REMARK 465 TRP B 446 REMARK 465 GLN B 447 REMARK 465 SER B 448 REMARK 465 SER B 449 REMARK 465 ILE B 450 REMARK 465 ALA B 451 REMARK 465 LEU B 452 REMARK 465 GLU B 453 REMARK 465 VAL B 454 REMARK 465 LEU B 455 REMARK 465 PHE B 456 REMARK 465 GLN B 457 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 277 70.01 57.42 REMARK 500 ALA B 34 89.67 -156.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-13200 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF HUMAN TTYH1 IN GDN DBREF 7P5J A 2 450 UNP Q9H313 TTYH1_HUMAN 2 450 DBREF 7P5J B 2 450 UNP Q9H313 TTYH1_HUMAN 2 450 SEQADV 7P5J MET A 0 UNP Q9H313 INITIATING METHIONINE SEQADV 7P5J SER A 1 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J ALA A 451 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J LEU A 452 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J GLU A 453 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J VAL A 454 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J LEU A 455 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J PHE A 456 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J GLN A 457 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J MET B 0 UNP Q9H313 INITIATING METHIONINE SEQADV 7P5J SER B 1 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J ALA B 451 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J LEU B 452 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J GLU B 453 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J VAL B 454 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J LEU B 455 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J PHE B 456 UNP Q9H313 EXPRESSION TAG SEQADV 7P5J GLN B 457 UNP Q9H313 EXPRESSION TAG SEQRES 1 A 458 MET SER GLY ALA PRO PRO GLY TYR ARG PRO SER ALA TRP SEQRES 2 A 458 VAL HIS LEU LEU HIS GLN LEU PRO ARG ALA ASP PHE GLN SEQRES 3 A 458 LEU ARG PRO VAL PRO SER VAL PHE ALA PRO GLN GLU GLN SEQRES 4 A 458 GLU TYR GLN GLN ALA LEU LEU LEU VAL ALA ALA LEU ALA SEQRES 5 A 458 GLY LEU GLY LEU GLY LEU SER LEU ILE PHE ILE ALA VAL SEQRES 6 A 458 TYR LEU ILE ARG PHE CYS CYS CYS ARG PRO PRO GLU PRO SEQRES 7 A 458 PRO GLY SER LYS ILE PRO SER PRO GLY GLY GLY CYS VAL SEQRES 8 A 458 THR TRP SER CYS ILE VAL ALA LEU LEU ALA GLY CYS THR SEQRES 9 A 458 GLY ILE GLY ILE GLY PHE TYR GLY ASN SER GLU THR SER SEQRES 10 A 458 ASP GLY VAL SER GLN LEU SER SER ALA LEU LEU HIS ALA SEQRES 11 A 458 ASN HIS THR LEU SER THR ILE ASP HIS LEU VAL LEU GLU SEQRES 12 A 458 THR VAL GLU ARG LEU GLY GLU ALA VAL ARG THR GLU LEU SEQRES 13 A 458 THR THR LEU GLU GLU VAL LEU GLU PRO ARG THR GLU LEU SEQRES 14 A 458 VAL ALA ALA ALA ARG GLY ALA ARG ARG GLN ALA GLU ALA SEQRES 15 A 458 ALA ALA GLN GLN LEU GLN GLY LEU ALA PHE TRP GLN GLY SEQRES 16 A 458 VAL PRO LEU SER PRO LEU GLN VAL ALA GLU ASN VAL SER SEQRES 17 A 458 PHE VAL GLU GLU TYR ARG TRP LEU ALA TYR VAL LEU LEU SEQRES 18 A 458 LEU LEU LEU GLU LEU LEU VAL CYS LEU PHE THR LEU LEU SEQRES 19 A 458 GLY LEU ALA LYS GLN SER LYS TRP LEU VAL ILE VAL MET SEQRES 20 A 458 THR VAL MET SER LEU LEU VAL LEU VAL LEU SER TRP GLY SEQRES 21 A 458 SER MET GLY LEU GLU ALA ALA THR ALA VAL GLY LEU SER SEQRES 22 A 458 ASP PHE CYS SER ASN PRO ASP PRO TYR VAL LEU ASN LEU SEQRES 23 A 458 THR GLN GLU GLU THR GLY LEU SER SER ASP ILE LEU SER SEQRES 24 A 458 TYR TYR LEU LEU CYS ASN ARG ALA VAL SER ASN PRO PHE SEQRES 25 A 458 GLN GLN ARG LEU THR LEU SER GLN ARG ALA LEU ALA ASN SEQRES 26 A 458 ILE HIS SER GLN LEU LEU GLY LEU GLU ARG GLU ALA VAL SEQRES 27 A 458 PRO GLN PHE PRO SER ALA GLN LYS PRO LEU LEU SER LEU SEQRES 28 A 458 GLU GLU THR LEU ASN VAL THR GLU GLY ASN PHE HIS GLN SEQRES 29 A 458 LEU VAL ALA LEU LEU HIS CYS ARG SER LEU HIS LYS ASP SEQRES 30 A 458 TYR GLY ALA ALA LEU ARG GLY LEU CYS GLU ASP ALA LEU SEQRES 31 A 458 GLU GLY LEU LEU PHE LEU LEU LEU PHE SER LEU LEU SER SEQRES 32 A 458 ALA GLY ALA LEU ALA THR ALA LEU CYS SER LEU PRO ARG SEQRES 33 A 458 ALA TRP ALA LEU PHE PRO PRO SER ASP ASP TYR ASP ASP SEQRES 34 A 458 THR ASP ASP ASP ASP PRO PHE ASN PRO GLN GLU SER LYS SEQRES 35 A 458 ARG PHE VAL GLN TRP GLN SER SER ILE ALA LEU GLU VAL SEQRES 36 A 458 LEU PHE GLN SEQRES 1 B 458 MET SER GLY ALA PRO PRO GLY TYR ARG PRO SER ALA TRP SEQRES 2 B 458 VAL HIS LEU LEU HIS GLN LEU PRO ARG ALA ASP PHE GLN SEQRES 3 B 458 LEU ARG PRO VAL PRO SER VAL PHE ALA PRO GLN GLU GLN SEQRES 4 B 458 GLU TYR GLN GLN ALA LEU LEU LEU VAL ALA ALA LEU ALA SEQRES 5 B 458 GLY LEU GLY LEU GLY LEU SER LEU ILE PHE ILE ALA VAL SEQRES 6 B 458 TYR LEU ILE ARG PHE CYS CYS CYS ARG PRO PRO GLU PRO SEQRES 7 B 458 PRO GLY SER LYS ILE PRO SER PRO GLY GLY GLY CYS VAL SEQRES 8 B 458 THR TRP SER CYS ILE VAL ALA LEU LEU ALA GLY CYS THR SEQRES 9 B 458 GLY ILE GLY ILE GLY PHE TYR GLY ASN SER GLU THR SER SEQRES 10 B 458 ASP GLY VAL SER GLN LEU SER SER ALA LEU LEU HIS ALA SEQRES 11 B 458 ASN HIS THR LEU SER THR ILE ASP HIS LEU VAL LEU GLU SEQRES 12 B 458 THR VAL GLU ARG LEU GLY GLU ALA VAL ARG THR GLU LEU SEQRES 13 B 458 THR THR LEU GLU GLU VAL LEU GLU PRO ARG THR GLU LEU SEQRES 14 B 458 VAL ALA ALA ALA ARG GLY ALA ARG ARG GLN ALA GLU ALA SEQRES 15 B 458 ALA ALA GLN GLN LEU GLN GLY LEU ALA PHE TRP GLN GLY SEQRES 16 B 458 VAL PRO LEU SER PRO LEU GLN VAL ALA GLU ASN VAL SER SEQRES 17 B 458 PHE VAL GLU GLU TYR ARG TRP LEU ALA TYR VAL LEU LEU SEQRES 18 B 458 LEU LEU LEU GLU LEU LEU VAL CYS LEU PHE THR LEU LEU SEQRES 19 B 458 GLY LEU ALA LYS GLN SER LYS TRP LEU VAL ILE VAL MET SEQRES 20 B 458 THR VAL MET SER LEU LEU VAL LEU VAL LEU SER TRP GLY SEQRES 21 B 458 SER MET GLY LEU GLU ALA ALA THR ALA VAL GLY LEU SER SEQRES 22 B 458 ASP PHE CYS SER ASN PRO ASP PRO TYR VAL LEU ASN LEU SEQRES 23 B 458 THR GLN GLU GLU THR GLY LEU SER SER ASP ILE LEU SER SEQRES 24 B 458 TYR TYR LEU LEU CYS ASN ARG ALA VAL SER ASN PRO PHE SEQRES 25 B 458 GLN GLN ARG LEU THR LEU SER GLN ARG ALA LEU ALA ASN SEQRES 26 B 458 ILE HIS SER GLN LEU LEU GLY LEU GLU ARG GLU ALA VAL SEQRES 27 B 458 PRO GLN PHE PRO SER ALA GLN LYS PRO LEU LEU SER LEU SEQRES 28 B 458 GLU GLU THR LEU ASN VAL THR GLU GLY ASN PHE HIS GLN SEQRES 29 B 458 LEU VAL ALA LEU LEU HIS CYS ARG SER LEU HIS LYS ASP SEQRES 30 B 458 TYR GLY ALA ALA LEU ARG GLY LEU CYS GLU ASP ALA LEU SEQRES 31 B 458 GLU GLY LEU LEU PHE LEU LEU LEU PHE SER LEU LEU SER SEQRES 32 B 458 ALA GLY ALA LEU ALA THR ALA LEU CYS SER LEU PRO ARG SEQRES 33 B 458 ALA TRP ALA LEU PHE PRO PRO SER ASP ASP TYR ASP ASP SEQRES 34 B 458 THR ASP ASP ASP ASP PRO PHE ASN PRO GLN GLU SER LYS SEQRES 35 B 458 ARG PHE VAL GLN TRP GLN SER SER ILE ALA LEU GLU VAL SEQRES 36 B 458 LEU PHE GLN HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG A 501 14 HET NAG A 502 14 HET NAG B 501 14 HET NAG B 502 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 8(C8 H15 N O6) HELIX 1 AA1 SER A 10 GLN A 18 1 9 HELIX 2 AA2 GLU A 37 CYS A 70 1 34 HELIX 3 AA3 THR A 91 VAL A 161 1 71 HELIX 4 AA4 GLU A 167 GLN A 187 1 21 HELIX 5 AA5 SER A 198 GLN A 238 1 41 HELIX 6 AA6 SER A 239 SER A 276 1 38 HELIX 7 AA7 PRO A 278 THR A 290 1 13 HELIX 8 AA8 SER A 293 CYS A 303 1 11 HELIX 9 AA9 PHE A 311 GLU A 335 1 25 HELIX 10 AB1 GLU A 335 PHE A 340 1 6 HELIX 11 AB2 PHE A 340 LEU A 368 1 29 HELIX 12 AB3 HIS A 369 GLU A 386 1 18 HELIX 13 AB4 ASP A 387 ALA A 418 1 32 HELIX 14 AB5 SER B 10 GLN B 18 1 9 HELIX 15 AB6 GLU B 37 CYS B 70 1 34 HELIX 16 AB7 THR B 91 VAL B 161 1 71 HELIX 17 AB8 GLU B 167 ALA B 190 1 24 HELIX 18 AB9 SER B 198 GLN B 238 1 41 HELIX 19 AC1 SER B 239 CYS B 275 1 37 HELIX 20 AC2 PRO B 280 THR B 290 1 11 HELIX 21 AC3 SER B 293 CYS B 303 1 11 HELIX 22 AC4 PHE B 311 GLU B 335 1 25 HELIX 23 AC5 GLU B 335 PHE B 340 1 6 HELIX 24 AC6 ALA B 343 LEU B 368 1 26 HELIX 25 AC7 HIS B 369 CYS B 385 1 17 HELIX 26 AC8 ASP B 387 ALA B 418 1 32 SSBOND 1 CYS A 275 CYS A 385 1555 1555 2.03 SSBOND 2 CYS A 303 CYS A 370 1555 1555 2.03 SSBOND 3 CYS B 275 CYS B 385 1555 1555 2.03 SSBOND 4 CYS B 303 CYS B 370 1555 1555 2.03 LINK ND2 ASN A 130 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN A 284 C1 NAG A 501 1555 1555 1.44 LINK ND2 ASN A 355 C1 NAG A 502 1555 1555 1.44 LINK ND2 ASN B 130 C1 NAG D 1 1555 1555 1.48 LINK ND2 ASN B 284 C1 NAG B 501 1555 1555 1.44 LINK ND2 ASN B 355 C1 NAG B 502 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.47 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.46 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000